DexCare, a data-driven intelligence company focused on healthcare access, has raised $50 million in a Series B funding led by Transformation Capital.
There was participation from all existing investors, Kaiser Permanente, Providence Ventures, Mass General Brigham, Define Ventures, Frist Cressey Ventures, and SpringRock Ventures.
In less than one year, DexCare has closed two oversubscribed funding rounds totaling $71 million to-date.
“This investment will help us accelerate platform development and go-to-market progress for our growing number of premier health systems such as Kaiser Permanente, Providence, Mass General Brigham, CHS, Houston Methodist and others,” said Derek Streat, Co-founder and CEO of DexCare.
DexCare is a Platform-as-a-Service (PaaS) for health systems that intelligently orchestrates digital demand and health system capacity. DexCare has developed an enterprise-grade real-time demand aggregation and appointment booking platform across all lines of care.
The new funds will be used to support and accelerate DexCare’s growth with investments in product and technology innovation, customer experience, and recruiting world class talent. The funding also enables DexCare to meet customer demand to expand into additional new service lines and care modalities.